1. Glycogen Storage Disease
  2. Efficacy and safety of empagliflozin in GSD type Ib: data from an international questionnaire survey | Webinar Recording

Efficacy and safety of empagliflozin in GSD type Ib: data from an international questionnaire survey | Webinar Recording

10th May 2022

Want to access this resource?

REGISTER NOW

OR LOGIN IF YOU ARE ALREADY REGISTERED

DESCRIPTION

A paediatric metabolic specialist presents international data on the growing use of empagliflozin to manage neutropenia in GSD type Ib.

Author

  • Dr Sarah Grünert

    University Children's Hospital Freiburg, Germany

TAGS

Glycogen Storage Disease

OTHER RESOURCES YOU MAY BE INTERESTED IN

Events
Practical issues in the dietary management of hepatic GSDs | Event Recording
Webinars
Ketotic GSDs; Faroe Islands and German Perspectives| Webinar Recording
Webinars
Ketotic glycogen storage diseases (GSD); current knowledge and evidence review | Webinar Recording
Practical Resources
Scientific Publication Compendium 2019 | Evidence Summary

WE HAVE A WEALTH OF RESOURCES FOR

PKU - Infants

PKU - Children

PKU - Adolescents and Adults

Maternal PKU

PKU & GMP

Rare disorders of protein metabolism

Lipid Disorders

Glycogen Storage Disease

Ketogenic Diet

K.Vita

Paediatric Kidney Disease

Nutrition Support